| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QRTEA | Restricted Stock Units - QRTEA | +Grant/Award | $0 | +14,188 | $0.00 | 14,188 | Dec 6, 2021 | Series A Common Stock | 14,188 | Direct | F1 | ||
| holding | QRTEA | Stock Option (right to buy) - QRTEA | 82,297 | Dec 6, 2021 | Series A Common Stock | 82,297 | $4.21 | Direct | F2, F3 | |||||
| holding | QRTEA | Stock Option (right to buy) - QRTEA | 27,198 | Dec 6, 2021 | Series A Common Stock | 27,198 | $8.84 | Direct | F4, F5 | |||||
| holding | QRTEA | Stock Option (right to buy) - QRTEA | 32,460 | Dec 6, 2021 | Series A Common Stock | 32,460 | $10.80 | Direct | F3, F6 | |||||
| holding | QRTEA | Stock Option (right to buy) - QRTEA | 28,338 | Dec 6, 2021 | Series A Common Stock | 28,338 | $11.50 | Direct | F3, F7 | |||||
| holding | QRTEA | Stock Option (right to buy) - QRTEA | 21,597 | Dec 6, 2021 | Series A Common Stock | 21,597 | $11.85 | Direct | F3, F8 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock. |
| F2 | On November 4, 2021, the Issuer announced that its board of directors declared a special cash dividend in the amount of $1.25 per common share payable on November 22, 2021, to all holders of record of the Issuer's common stock at the close of business on November 15, 2021 (the "Dividend"). This stock option award was previously reported as an option relating to 70,209 shares of the Issuer's Series A common stock at an exercise price of $4.92 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended ("Rule 16b-3"). |
| F3 | The derivative security is fully vested. |
| F4 | This stock option award was previously reported as an option relating to 24,726 shares of the Issuer's Series A common stock at an exercise price of $10.34 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3. |
| F5 | This stock option award was granted on December 10, 2020, and vests 100% on December 10, 2021. |
| F6 | This stock option award was previously reported as an option relating to 27,746 shares of the Issuer's Series A common stock at an exercise price of $12.64 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3. |
| F7 | This stock option award was previously reported as an option relating to 24,215 shares of the Issuer's Series A common stock at an exercise price of $13.46 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3. |
| F8 | This stock option award was previously reported as an option relating to 18,453 shares of the Issuer's Series A common stock at an exercise price of $13.87 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3. |
Exhibit List: Ex. 24 - Power of Attorney.